SARS-CoV-2 vaccination status and adverse events among patients with psoriasis-Data from the German Registries PsoBest and CoronaBest

Affiliations

¹ Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
² Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
³ Psoriasis Center Kiel, Department of Dermatology, Venereology and Allergology University Medical Center Schleswig-Holstein, Kiel, Germany.
⁴ Department of Dermatology and Allergy, University Medical Center Mainz, Mainz, Germany.
⁵ Dermatological Practice Selters, Selters, Germany.

María José Valencia López et al. J Eur Acad Dermatol Venereol. 2023 Jul.

. 2023 Jul;37(7):e831-e833.

doi: 10.1111/jdv.19039. Epub 2023 Mar 27.

¹ Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
² Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
³ Psoriasis Center Kiel, Department of Dermatology, Venereology and Allergology University Medical Center Schleswig-Holstein, Kiel, Germany.
⁴ Department of Dermatology and Allergy, University Medical Center Mainz, Mainz, Germany.
⁵ Dermatological Practice Selters, Selters, Germany.

No abstract available

References

1. Gisondi P, Mrowietz U, Garcia-Doval I. Vaccination against SARS-CoV-2 in people with psoriasis disease. EuroGuiDerm Consensus statement - Updated version January 2022. 2022. Available at: https://derma.de/fileadmin/PDF-Dateien/EuroGuiDerm_Pso_SarsCov2Vacc_Apri.... Accessed 21 September 2022.
1. Niehues T, Bogdan C, Hecht J, Mertens T, Wiese-Posselt M, Zepp F. Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen(I) Grundlagenpapier. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017;60:674-84.
1. Aktueller Impfstatus. 2022. Available at: https://www.impfdashboard.de. Accessed 18 November 2022.
1. Talamonti M, Galluzzo M. Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents. Expert Opin Biol Ther. 2021;21:1535-7.
1. Cristaudo A, Graceffa D, Pimpinelli F, Sperati F, Spoletini G, Bonifati C, et al. Immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs. J Eur Acad Dermatol Venereol. 2022;36:e266-8.